To guide this extensive revision, MoSPI has constituted an Advisory Committee on National Account Statistics (ACNAS) chaired ...

Abivax receives a "Strong Buy" rating, driven by positive phase 3 ABTECT induction data for obefazimod in moderate-to-severe ...

Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more ...

In a discussion paper issued on Tuesday, the Ministry of Statistics and Programme Implementation (MoSPI) has proposed ...

Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target effects ...

The Indigenous Data Sovereignty movement calls for greater community control over how First Nations data is collected, ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that at the 2025 ESMO Asia Congress, updated results from the pivotal Phase III HARMONi-6 study (AK112-306) were shared in an oral ...

(11/15 participants) improved on the Overall Cutaneous Venous Malformations Investigator Global Assessment (Overall ...

Australia's economy grew at the fastest annual pace in two years in the September quarter, fuelled by business, government and consumer spending as markets wagered the next move in interest rates ...

Current account recorded €26 billion surplus in October 2025, up from €24 billion in previous monthCurrent account surplus amounted to €313 billion ...

Early Alzheimer's patients who completed their course of donanemab therapy by 12 months had cognitive and functional benefits lasting for 2 additional years, reported Jennifer Zimmer, MD, of Eli Lilly ...

Somehow even I was surprised by the levels of shamelessness on display following the publication of the latest education statistics this ...